| Financial Year |
March 31 2023 |
| Monetary Funds |
7,044,145,186.50 |
| Held-for-trading Financial Assets |
901,139,980.68 |
| Notes Receivable |
-- |
| Accounts Receivable |
782,580,382.74 |
| Advances to Suppliers |
177,727,701.70 |
| Other Receivables |
65,006,996.91 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
3,371,489,232.54 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
760,580,129.33 |
| Total Current Assets |
13,102,669,610.40 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
141,733.98 |
| Investment Properties |
829,922,330.19 |
| Fixed Assetes |
1,777,952,651.98 |
| Under-construction Projects |
17,360,051.98 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
382,353,093.77 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
54,281,924.95 |
| Deferred Income Tax Assets |
418,571,902.20 |
| Other Non-Current Assets |
330,076,256.47 |
| Sub-Total of Non-Current Assets |
4,472,528,917.87 |
| Total Assets |
17,575,198,528.27 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
3,158,766,655.57 |
| Accounts Payable |
1,493,600,779.48 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
122,200,488.46 |
| Taxes Payable |
230,062,257.59 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
200,275,830.25 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
164,657,488.25 |
| Other Current Liabilities |
596,264,423.59 |
| Sub-Total of Current Liabilities |
6,154,054,981.88 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
13,973,956.25 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
215,962,849.62 |
| Total Liabilities |
6,370,017,831.50 |
| Paid-In Capital(Or Share Stock) |
2,694,090,160.00 |
| Capital Surplus |
2,812,953,696.94 |
| Surplus Reserve |
1,574,219,107.70 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
4,320,878,550.39 |
| Minority Stockholder's Interest |
-7,036,585.03 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
11,212,217,281.80 |
| Owner's Equity（Stockholder's Equity） |
11,205,180,696.77 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
17,575,198,528.27 |
